LOGIN
ISAKOS: MACI Implant superior compared to Microfracture for articular cartilage defects
May 2013
ISAKOS: MACI Implant superior compared to Microfracture for articular cartilage defects
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Matrix-Induced Autologous Chondrocyte Implant vs. Microfracture: Prospective, Randomized Trial in European Patients, 2-Year Follow Up
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
To investigate the use of matrix-induced autologous implant (MACI) in treatment of symptomatic articular cartilage defects of the knee, the phase 3 of the SUMMIT trial randomised 144 patients to either matrix-induced autologous implant (MACI) or microfracture group. At a 2 year follow up, MACI group demonstrated significantly better pain and functional outcomes with no adverse events.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.